Table 4.
Treatment description | Mean weight (mg) (95% confidence interval) | Range (mg) | Adjusted P value versus 21 bp DvSSJ1 in GFP | P value versus GFP control |
---|---|---|---|---|
RNAse free H2O | 1.93 (1.61–2.26) | 0.4–3.5 | < 0.0001* | 0.9374 |
GFP control (210 bp GFP) | 1.95 (1.59–2.31) | 0.2–3.3 | < 0.0001* | – |
DvSSJ1 21 bp embedded within 210 bp GFP | 0.375 (-0.183–0.933) | 0.1–1.1 | – | < 0.0001* |
DvSSJ1 1 bp point mutation (loc 1) | 1.03 (0.593–1.47) | 0.3–2.3 | 0.2387 | 0.0016* |
DvSSJ1 2 bp point mutations (locs 1, 3) | 1.23 (0.903–1.55) | 0.1–2.3 | 0.0445* | 0.0034* |
DvSSJ1 3 bp point mutations (locs 1, 3, 5) | 1.85 (1.52–2.18) | 0.3–3.2 | < 0.0001* | 0.6728 |
DvSSJ1 4 bp point mutations (locs 1, 3, 5, 7) | 1.62 (1.29–1.94) | 0.2–3.0 | 0.0012* | 0.1727 |
DvSSJ1 5 bp point mutations (locs 1, 3, 5, 7, 9) | 2.00 (1.67–2.33) | 0.4–2.8 | < 0.0001* | 0.8486 |
DvSSJ1 1 bp point mutation (loc 11) | 1.37 (1.05–1.68) | 0.3–3.0 | 0.0130* | 0.0173* |
DvSSJ1 210 bp dsRNA | 1.40 ± 0.707 | 0.9–1.9 | – | – |
Increasing single nucleotide polymorphisms (SNPs) were introduced in various locations (loc) within the DvSSJ1 21-mer and fed to WCR over 14 days to assess WCR weight.
*A statistically significant difference (P value < 0.05) was observed.